A Randomized, Double-Blind, Placebo-Controlled Trial of Porcine Versus Synthetic Secretin for Reducing Symptoms of Autism

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 41, Issue 11, 2002, Pages 1315-1321

  Unis, Alan S ^a   Munson, Jeffrey A ^b   Rogers, Sally J ^c   Goldson, Ed ^c   Osterling, Julie ^b   Gabriels, Robin ^c   Abbott, Robert D ^b   Dawson, Geraldine ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Autism; Psychopharmacology; Secretin

Indexed keywords

PLACEBO; SECRETIN; GASTROINTESTINAL AGENT;

ANALYSIS OF VARIANCE; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FOLLOW UP; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; OBSERVATION; OUTCOMES RESEARCH; PARENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE; SKILL; SYMPTOM; CLASSIFICATION; COMPARATIVE STUDY;

AUTISTIC DISORDER; CHILD; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; QUESTIONNAIRES; SECRETIN;

EID: 0036831724     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200211000-00012     Document Type: Article

References (20)

1. Aman MG, Singh NN, Stewart AW, Field CJ (1985), The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 89:485-491
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Charlton CG, Miller RL, Crawley JN, Handelmann GE, O'Donohue TL (1983), Secretin modulation of behavioral and physiological functions in the rat. Peptides 4:739-742
4. Chez MG, Buchanan CP, Bagan BT et al. (2000), Secretin and autism: a two-part clinical investigation. J Autism Dev Disord 30:87-94
5. Coniglio SJ, Lewis JD, Lang C et al. (2001), A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr 138:649-655
6. Corbett B, Khan K, Czapansky-Beilman D et al. (2001), A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Clin Pediatr (Phila) 40:327-331
7. D'Eufemia P, Celli M, Finocchiaro R et al. (1996), Abnormal intestinal permeability in children with autism. Acta Paediatr 85:1076-1079
8. Dunn-Geier J, Ho HH, Auersperg E et al. (2000), Effect of secretin on children with autism: a randomized controlled trial. Dev Med Child Neurol 42:796-802
9. Fenson L, Dale PS, Reznick JS et al. (1993), The MacArthur Communicative Development Inventories: User's Guide and Technical Manual. San Diego, CA: Singular Publishing Group
10. Gardener MF (1990), Expressive One-Word Picture Vocabulary Test-Revised. Novato, CA: Academic Therapy Publications
11. Gilliam J (1995), Gilliam Autism Rating Scale. Austin, TX: Pro-Ed
12. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999), Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135:559-563
13. Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT (1998), Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 9:9-15
14. Krug DA, Arick JR, Almond PJ (1993), Autism Screening Instrument for Educational Planning, 2nd ed. Austin, TX: Pro-Ed
15. Lord C, Risi S, Lambrecht L et al. (2000), The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205-223
16. Owley T, McMahon W, Cook EH et al. (2001), Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry 40:1293-1299
17. Owley T, Steele E, Corsello C et al. (1999), A double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder. MedGenMed Oct 6:E2 (http://www.medscape.com/Medscape/GeneralMedicine/journal/1999/v01.n10/mgm1006. owle/mgm1006.owle-01.html)
18. Roberts W, Weaver L, Brian J et al. (2001), Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics 107:E71
19. Sandler AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish JW (1999), Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 341:1801-1806
20. Wakefield AJ, Murch SH, Anthony A et al. (1998), Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641